Dale Sander

Dale Sander

Director of Finance/CFO at HUMACYTE, INC.

Net worth: 201 002 $ as of 31/07/2026

66 year
Health Technology
Commercial Services
Distribution Services

Profile

Dale A. Sander is currently Chief Financial Officer & Treasurer at Humacyte Global, Inc. since 2021 and Chief Financial Officer & Treasurer at Humacyte, Inc. since 2021.
Former roles include Chief Financial Officer at Maxim Pharmaceuticals, Inc. from 1996 to 2004; Chief Financial Officer & SVP-Finance at Biolex Therapeutics, Inc.; Chief Financial Officer at Tactyl Technologies, Inc. from 1993 to 1996; Senior Vice President & Global Accounting Officer at Sutherland Global Services, Inc. from 2012 to 2017; Chief Financial Officer at Juventas Therapeutics, Inc.; Chief Financial Officer at AVITA Medical Pty Ltd. from 2017 to 2019; Chief Financial Officer at Xytronyx, Inc. from 1993 to 1996; Senior Manager at Ernst & Young LLP from 1982 to 1991; Chief Financial Officer at Bryn Pharma LLC from 2019 to 2021; and Chief Financial Officer at AVITA Medical, Inc. from 2017 to 2019.
Education includes undergraduate studies at San Diego State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
18/05/2026 307,813 ( 0.11% ) 201 002 $ 31/07/2026

Dale Sander active positions

CompaniesPositionStart
HUMACYTE, INC. Director of Finance/CFO 26/08/2021
Director of Finance/CFO 19/05/2021

Former positions of Dale Sander

CompaniesPositionEnd
Director of Finance/CFO 01/01/2021
AVITA MEDICAL, INC. Director of Finance/CFO 15/05/2019
Director of Finance/CFO 15/05/2019
Comptroller/Controller/Auditor 01/01/2017
Director of Finance/CFO 01/04/2004
See the detail of Dale Sander's experience

Training of Dale Sander

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

83

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Commercial Services

Distribution Services

Health Technology

Consumer Non-Durables

Consumer Services

Technology Services

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology